journal article·2026-08Open access

A catalytically active and recyclable bioelastomer inspired by metalloenzymes

Cole Latvis, Mark Garren, Nathaniel Wright, Katelyn Ge, Zhenyu Li, Hanshuang Shao, Christopher J. Pollock, Hitesh Handa, Elizabeth Brisbois, Simon Van Herck, Alan Wells, Yadong Wang

Abstract

Catalysis is a fundamental principle of biological systems, yet synthetic biomaterials seldom incorporate catalytic activity as a core design principle. Here, we introduce a polymeric network constructed by crosslinking imidazole-functionalized polymers using Cu 2+ ions, yielding an elastomer with enzyme-mimetic reactivity. This bioinspired design enables sustained nitric oxide (NO) generation in serum and broad-spectrum antioxidant activity against superoxide, hydrogen peroxide, and hydroxyl radicals, mimicking the functions of superoxide dismutase, catalase, and peroxidases. Catalytic activity depends on Cu 2+ coordination, confirming a defined structure-function mechanism. The elastomer demonstrates minimal hemolysis, reduced platelet adhesion, and high biocompatibility upon subcutaneous implantation. Remarkably, the material can be fully recycled by a simple immersion in acetic acid that reverses Cu 2+ coordination without compromising the integrity of the polymer. This closed-loop feature aligns with circular economy principles and greatly extends the functional lifespan of the material. By integrating mechanical robustness, catalytic activity, and recyclability, this material bridges a critical gap between natural and engineered systems, establishing a new framework for catalytically active and sustainable biomaterials. • Minute amount of copper ions form crosslinks in a tough elastomer. • The materials have inherent catalytic activities. • Bioactivity 1: sustained N itric O xide generation. • Bioactivity 2: broad-spectrum R eactive O xygen S pecies scavenging. • The bioactive material is fully recyclable without loss of function.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Polymer Surface Interaction Studies · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (83)

Show source-provided references
1. Drug-eluting stents in vascular intervention10.1016/S0140-6736(03)12275-1 ↗
2. Surface modification of polymers by plasma treatments for the enhancement of biocompatibility and controlled drug release10.1016/j.surfcoat.2013.02.042 ↗
3. Stimulus-Responsive targeted nanomicelles for effective cancer therapy10.2217/nnm.09.44 ↗
4. The use of intraocular corticosteroids10.1517/14656560903160671 ↗
5. Designs, applications, and future perspectives of nanozymes in orthopedics and dentistry10.22203/eCM.v052a06 ↗
6. The multiple roles of urocanic acid in health and disease10.1016/j.jid.2020.07.017 ↗
7. Microbial production of 1,3-propanediol10.1007/s002530051523 ↗
8. Optimization study for metabolomics analysis of human sweat by liquid chromatography–tandem mass spectrometry in high resolution mode10.1016/j.chroma.2014.01.071 ↗
9. A critical assessment of the evidence from XAFS and crystallography for the breakage of the imidazolate bridge during catalysis in CuZn superoxide dismutase10.1016/S0969-2126(97)00194-9 ↗
10. Combined EXAFS and DFT structure calculations provide structural insights into the 1:1 multi-histidine complexes of CuII, CuI, and ZnII with the tandem octarepeats of the Mammalian prion protein10.1002/chem.201304201 ↗
11. X-ray absorption spectroscopy of metal-histidine coordination in metalloproteins. Exact simulation of the EXAFS of tetrabis(imidazole)copper(II) nitrate and other copper-imidazole complexes by the use of a multiple-scattering treatment10.1021/ja00257a042 ↗
12. A key structural role for active site type 3 copper ions in human ceruloplasmin10.1074/jbc.M207188200 ↗
13. Mitochondrial copper metabolism and delivery to cytochrome c oxidase10.1002/iub.50 ↗
14. Determination and analysis of the 2 Å structure of copper, zinc superoxide dismutase10.1016/0022-2836(82)90174-7 ↗
15. Cellular mechanisms and physiological consequences of redox-dependent signalling10.1038/nrm3801 ↗
16. H2O2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine10.1161/01.HYP.16.2.162 ↗
17. Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species10.1152/ajpcell.00322.2010 ↗
18. Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage10.3858/emm.2010.42.3.018 ↗
19. Hydrogen peroxide as a mediator of programmed cell death in the blastocyst10.1111/j.1432-0436.1991.tb00880.x ↗
20. Evidence of oxidative stress in chronic venous ulcers10.1046/j.1524-475X.2003.11304.x ↗
21. Biological production, detection, and fate of hydrogen peroxide10.1089/ars.2017.7425 ↗
22. The molecular mechanism of the catalase reaction10.1021/ja9018572 ↗
23. Interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide. Inactivation of the enzyme10.1021/bi00695a010 ↗
24. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases10.1038/s41467-020-16544-7 ↗
25. O−2 Decay catalyzed by Cu2+ and Cu+ ions in aqueous solutions: a pulse radiolysis Study for atmospheric chemistry10.1002/bbpc.19930970604 ↗
26. Investigation of the generation of hydroxyl radicals and their oxidative role in the presence of heterogeneous copper catalysts10.1016/j.chemosphere.2007.05.041 ↗
27. Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem10.1016/j.biomaterials.2020.120278 ↗
28. Targeted alleviation of ischemic stroke reperfusion via atorvastatin-ferritin Gd-layered double hydroxide
29. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria10.1016/0003-9861(77)90035-2 ↗
30. An NADPH oxidase superoxide-generating system in the rabbit aorta10.1152/ajpheart.1995.268.6.H2274 ↗
31. Quantitative aspects of the production of superoxide anion radical by milk Xanthine oxidase10.1016/S0021-9258(18)62884-4 ↗
32. Mitochondria and reactive oxygen species10.1016/j.freeradbiomed.2009.05.004 ↗
33. Investigations of riboflavin photolysis via coloured light in the nitro blue tetrazolium assay for superoxide dismutase activity10.1016/j.jphotobiol.2015.04.028 ↗
34. Roles and current applications of S-nitrosoglutathione in anti-infective biomaterials
35. The blood compatibility challenge. Part 2: protein adsorption phenomena governing blood reactivity10.1016/j.actbio.2019.06.022 ↗
36. PdAu alloy nanoparticle catalysts: effective candidates for nitrite reduction in water10.1021/acscatal.6b03647 ↗
37. Bio-inspired hemocompatible surface modifications for biomedical applications10.1016/j.pmatsci.2022.100997 ↗
38. Estimation of nitric oxide production and reactionrates in tissue by use of a mathematical model10.1152/ajpheart.1998.274.6.H2163 ↗
39. Water-Stable metal-organic Framework/Polymer composites compatible with human hepatocytes10.1021/acsami.6b05948 ↗
40. Surface-Catalyzed nitric oxide release via a metal organic framework enhances antibacterial surface effects10.1021/acsami.1c17248 ↗
41. Progress and promise of nitric oxide-releasing platforms
42. Metal-Organic Framework/Chitosan hybrid materials promote nitric oxide release from S-Nitrosoglutathione in aqueous solution10.1021/acsami.6b14937 ↗
43. Polyurethane with tethered copper(II)–cyclen complex: preparation, characterization and catalytic generation of nitric oxide from S-nitrosothiols10.1016/j.biomaterials.2008.02.004 ↗
44. Multifunctional S-Nitroso-N-acetylpenicillamine-Incorporated medical-grade polymer with selenium interface for biomedical applications10.1021/acsami.9b10610 ↗
45. Tunable nitric oxide release from S-Nitroso-N-acetylpenicillamine via catalytic copper nanoparticles for biomedical applications10.1021/acsami.7b01408 ↗
46. Cu(II)-Organic coordination polymer networks for persistent nitric oxide release in tumor therapy10.1021/acs.biomac.4c01071 ↗
47. Complement inhibition in biomaterial- and biosurface-induced thromboinflammation10.1016/j.smim.2016.04.006 ↗
48. Nitric oxide and its antithrombotic action in the cardiovascular system10.2174/1568006053005047 ↗
49. Effects of extracellular matrix viscoelasticity on cellular behaviour10.1038/s41586-020-2612-2 ↗
50. A tough biodegradable elastomer10.1038/nbt0602-602 ↗
51. Recombinant human elastin polypeptides self-assemble into biomaterials with elastin-like properties10.1002/bip.10512 ↗
52. Elastic proteins: biological roles and mechanical properties10.1098/rstb.2001.1022 ↗
53. Chelation crosslinking of biodegradable elastomers10.1002/adma.202003761 ↗
54. Mechanical characterisation of polyurethane elastomer for biomedical applications10.1016/j.jmbbm.2009.03.005 ↗
55. Properties of polyurethane thin films
56. Polyurethane elastomers with low modulus and hardness based on novel copolyether macrodiols10.1002/(SICI)1097-4628(19970307)63:10<1373::AID-APP18>3.0.CO;2-5 ↗
57. On the large strain deformation behavior of silicone-based elastomers for biomedical applications10.1016/j.polymertesting.2016.12.029 ↗
58. Dynamic covalent polymer networks with mechanical and mechanoresponsive properties reinforced by strong hydrogen bonding10.1039/D2PY00179A ↗
59. The influence of hydrogen bonding side-groups on viscoelastic behavior of Linear and network polymers10.1021/ma402368s ↗
60. Impact of matrix stiffness on fibroblast function10.1016/j.msec.2017.02.001 ↗
61. Study of stiffness effects of poly(amidoamine)–poly(n-isopropyl acrylamide) hydrogel on wound healing10.1016/j.colsurfb.2015.08.041 ↗
62. Mechanism of regulation of stem cell differentiation by matrix stiffness10.1186/s13287-015-0083-4 ↗
63. Mechanics of breathing
64. Function–structure relationship of elastic arteries in evolution: from microfibrils to elastin and elastic fibres10.1016/S0369-8114(01)00147-X ↗
65. 2002
66. Copper as an essential nutrient10.1093/ajcn/63.5.791 ↗
67. Copper promotion of angiogenesis in isolated rat aortic ring: role of vascular endothelial growth factor10.1016/j.jnutbio.2013.08.013 ↗
68. Biocompatibility analysis of PLA based candidate materials for cardiovascular stents in a rat subcutaneous implant model10.1016/j.acthis.2020.151615 ↗
69. Subcutaneous tissue response to titanium, poly(ϵ-caprolactone), and carbonate-substituted hydroxyapatite-coated poly(ϵ-caprolactone) plates: a rabbit study10.1002/jbm.a.34542 ↗
70. Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring10.2353/ajpath.2010.090564 ↗
71. Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-Negative CXC chemokine receptor10.2353/ajpath.2007.061092 ↗
72. Phagocytic leukocytes and reactive oxygen species10.1007/s00418-009-0565-5 ↗
73. Reactive oxygen species scavenging potential contributes to hypertrophic scar Formation10.1016/j.jss.2019.06.006 ↗
74. The role of oxidative stress and antioxidants in diabetic wound healing10.1155/2021/8852759 ↗
75. Thermal 1,3-Trityl migrations in diels−alder domino reactions of 1-Trityl-4-vinyl-1H-imidazoles10.1021/jo100416c ↗
76. Room temperature polyesterification10.1021/ma00203a013 ↗
77. Nitric oxide measurement by chemiluminescence detection10.1016/1058-6741(92)90045-Y ↗
78. Nitric oxide generation from endogenous substrates using metal–organic frameworks: inclusion within Poly(vinyl alcohol) membranes to investigate reactivity and therapeutic potential10.1021/acsami.7b11846 ↗
79. Ceria nanoparticles as an unexpected catalyst to generate nitric oxide from S-Nitrosoglutathione10.1002/smll.202105762 ↗
80. Nitric oxide and S-nitrosothiols in human blood10.1016/S0009-8981(03)00046-9 ↗
81. Dual action nitric oxide and fluoride ion-releasing hydrogels for combating dental caries10.1021/acsami.2c02301 ↗
82. Requirement of the chemokine receptor CXCR3 for acute allograft rejection10.1084/jem.192.10.1515 ↗
83. Matricellular protein Tenascin-C enhances mesenchymal stem cell angiogenic and wound healing efficacy under ischemic conditions10.1002/term.3367 ↗